Rick Bright arrives to testify before the House Energy and Commerce Subcommittee on Health on May 14, 2020, in Washington, DC. (Greg Nash, POOL/AFP via Getty Images)
May 14, 2020 11:57 AM EDTUpdated 03:23 PM
People
Coronavirus

Rick Bright de­tails mis­man­aged pan­dem­ic re­sponse, warns of drugs, vac­cine sup­ply prob­lems down the road; HHS push­es back

Jason Mast

Editor

In wide-rang­ing con­gres­sion­al tes­ti­mo­ny, the oust­ed head of an agency at the cen­ter of the fed­er­al gov­ern­ment’s Covid-19 vac­cine and treat­ment re­sponse crit­i­cized the Trump …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times